Larimar Therapeutics Inc. (LRMR)
AI Score
Our AI model analyzes fundamental, technical, and statistical indicators
to predict the probability of a bullish trend over the next three months.
We regularly update and refine our models to deliver the most reliable forecasts
for you.
Bullish Probability | Sentiment | Score |
---|---|---|
+80% | Strong Buy | 10 |
+75% | Buy | 9 |
+70% | Buy | 8 |
+60% | Buy | 7 |
+50% | Hold | 6 |
+45% | Hold | 5 |
+40% | Hold | 4 |
+35% | Sell | 3 |
+30% | Sell | 2 |
+20% | Strong Sell | 1 |
3.44
0.15 (4.56%)
At close: Jan 15, 2025, 9:35 AM
Income Statement (Annual)
Get detailed income statement breakdowns, uncovering revenue, expenses, and much more.
Year | FY23 | FY22 | FY21 | FY20 | FY19 | FY18 | FY17 | FY16 | FY15 | FY14 | FY13 | FY12 | FY11 |
Revenue | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Cost of Revenue | 311.00K | 272.00K | 326.00K | 155.00K | 78.00K | 261.00K | 188.00K | 212.00K | 70.00K | n/a | 12.00K | 11.00K | 4.00K |
Gross Profit | -311.00K | -272.00K | -326.00K | -155.00K | -78.00K | -261.00K | -188.00K | -212.00K | -70.00K | n/a | -12.00K | -11.00K | -4.00K |
Operating Income | -41.76M | -36.53M | -50.47M | -42.80M | -23.21M | -62.72M | -53.88M | -57.12M | -73.81M | -35.53M | -13.78M | -13.79M | -13.15M |
Interest Income | n/a | n/a | n/a | n/a | n/a | n/a | 996.00K | 894.00K | 438.00K | 28.00K | n/a | n/a | n/a |
Pretax Income | -36.95M | -35.35M | -50.64M | -42.48M | -23.13M | -62.97M | -52.93M | -58.18M | -74.29M | -36.57M | -14.03M | -13.88M | -13.16M |
Net Income | -36.95M | -34.18M | -50.31M | -42.33M | -23.13M | -61.37M | -52.03M | -57.88M | -74.29M | -36.57M | -14.03M | -13.88M | -13.16M |
Selling & General & Admin | 14.09M | 12.28M | 12.07M | 11.40M | 2.42M | 12.93M | 11.95M | 17.14M | 19.13M | 8.14M | 4.21M | 2.24M | 1.75M |
Research & Development | 27.36M | 24.25M | 38.40M | 31.41M | 20.79M | 49.53M | 41.74M | 39.77M | 54.62M | 27.39M | 9.56M | 11.54M | 11.40M |
Other Expenses | n/a | 1.17M | -171.00K | 322.00K | 82.00K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Operating Expenses | 41.76M | 36.53M | 50.47M | 42.80M | 23.21M | 62.46M | 53.69M | 56.91M | 73.74M | 35.53M | 13.77M | 13.78M | 13.15M |
Interest Expense | n/a | n/a | n/a | n/a | n/a | n/a | 971.00K | 347.00K | 806.00K | -870.00K | n/a | 97.00K | n/a |
Selling & Marketing Expenses | n/a | n/a | n/a | n/a | n/a | 12.93M | -212.00K | -1.15M | -70.00K | n/a | n/a | n/a | n/a |
Cost & Expenses | 41.76M | 36.53M | 50.47M | 42.80M | 23.21M | 62.72M | 53.88M | 57.12M | 73.81M | 35.53M | 13.78M | 13.79M | 13.15M |
Income Tax | n/a | -1.17M | -326.00K | -155.00K | -93.86K | -1.60M | -900.00K | -300.00K | -946.00K | n/a | n/a | n/a | n/a |
Shares Outstanding (Basic) | 43.90M | 25.76M | 17.16M | 11.88M | 9.21M | 2.69M | 2.29M | 2.27M | 2.23M | 2.42M | 2.18M | 2.18M | 2.18M |
Shares Outstanding (Diluted) | 43.90M | 25.76M | 17.16M | 11.88M | 9.21M | 2.69M | 2.29M | 2.27M | 2.23M | 2.42M | 2.18M | 2.18M | 2.18M |
EPS (Basic) | -0.84 | -1.33 | -2.93 | -3.56 | -2.51 | -22.85 | -22.76 | -25.44 | -33.32 | -15.14 | -6.54 | -6.4 | -6.07 |
EPS (Diluted) | -0.84 | -1.33 | -2.93 | -3.56 | -2.51 | -22.85 | -22.76 | -25.44 | -33.32 | -15.14 | -6.54 | -6.4 | -6.07 |
EBITDA | -41.45M | -35.08M | -50.14M | -42.65M | -23.14M | -60.81M | -52.58M | -57.44M | -73.41M | -35.53M | -14.02M | -13.77M | -13.15M |
Depreciation & Amortization | 311.00K | 272.00K | 326.00K | 155.00K | 78.00K | 261.00K | 188.00K | 212.00K | 70.00K | n/a | 12.00K | 11.00K | 4.00K |